prostate cancer
Researchers say is could 'reduce the need for toxic chemotherapy'.
Patients treated with the drug for 12 months were found to have a 37% increased risk of depression.
It's the most common cancer in men in the UK.
"Today’s findings...could change the treatment of prostate cancer forever."